997 Results
General Treatment Recommendations and Resources
Learn more about treating historically marginalized populations experiencing stress and trauma related to changing political and social environments.
Choosing Wisely
On April 23, 2015 APA published a revision to the third item on its Choosing Wisely list to better reflect that there are instances in which dementia-associated symptoms (e.g., aggressive behavior due to paranoid delusions) pose an acute threat to the individual and others, and in these instances antipsychotic medications must be used before formal nonpharmacologic measures can be instituted.
What are Personality Disorders?
What are personality disorders? A personality disorder is a way of thinking, feeling and behaving that deviates from the expectations of the culture, causes distress or problems functioning, and lasts over time.
What Are Dissociative Disorders?
Learn about dissociative disorders, including symptoms, risk factors, treatment options and answers to common questions.
FDA Approves Novel Depression Treatment
Last month, esketamine nasal spray became the first treatment for depression with a new mechanism of action approved by the Food and Drug Administration (FDA) since Prozac (fluoxetine hydrochloride) was approved in the late 1980s. Esketamine (sold as Spravato) has the potential to be extremely useful for people who have not responded to other treatments. Used in combination with an oral anti-depressant, it can take effect much faster than many common antidepressant medications. However, it comes
Structural Racism Task Force
The APA Presidential Task Force to Address Structural Racism Throughout Psychiatry was formed by APA President Dr. Jeffrey Geller in June 2020.
Covid-19 / Coronavirus
To provide support in the response to the novel coronavirus (COVID-19), APA is collecting credible and useful resources in this information hub.
Making the Case: Medicaid Payment for the Collaborative Care Model
View resources for psychiatrists advocating for Medicaid payment for the Collaborative Care Model.
Cannabis
Learn about various aspects of treating cannabis use disorders, including clinical, training, and policy considerations. As new topics emerge, more resources and information will be added to this page. The resources covers topics from the APA Work Group on Cannabis with the Council on Addiction Psychiatry, training, practice/clinical, and legal issues from leading psychiatrists.